Delong Liu Selected Research

Lymphoid Leukemia

1/2019	Frontline therapies for untreated chronic lymphoid leukemia.
10/2018	Venetoclax and low-dose cytarabine induced complete remission in a patient with high-risk acute myeloid leukemia: a case report.
1/2017	Syk inhibitors in clinical development for hematological malignancies.
1/2016	Successful treatment of ibrutinib-associated central nervous system hemorrhage with platelet transfusion support.
11/2015	ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Delong Liu Research Topics

Disease

45	Neoplasms (Cancer) 05/2022 - 08/2004
15	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 08/2002
9	Leukemia 11/2019 - 08/2002
9	Lymphoma (Lymphomas) 01/2019 - 05/2005
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 08/2002
7	Hematologic Neoplasms (Hematological Malignancy) 07/2021 - 08/2002
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 08/2002
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2018 - 01/2011
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017 - 01/2016
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2017 - 08/2011
5	Multiple Myeloma 01/2020 - 10/2019
5	Lymphoid Leukemia 01/2019 - 11/2015
5	Prostatic Neoplasms (Prostate Cancer) 05/2016 - 01/2004
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016 - 06/2004
4	Carcinogenesis 10/2014 - 01/2004
3	Infections 10/2021 - 10/2010
3	Neutropenia 10/2021 - 11/2010
3	Bites and Stings (Sting) 01/2020 - 11/2012
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 10/2012
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018 - 08/2012
3	Thrombocytopenia (Thrombopenia) 01/2017 - 11/2010
3	Melanoma (Melanoma, Malignant) 04/2013 - 02/2012
2	Scoliosis 10/2022 - 08/2020
2	Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis) 01/2020 - 01/2018
2	Lung Neoplasms (Lung Cancer) 11/2019 - 04/2013
2	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 01/2014
2	Cytokine Release Syndrome 01/2018 - 01/2014
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2017 - 03/2016
2	Babesiosis (Piroplasmosis) 01/2017 - 01/2017
2	Hemorrhage 01/2016 - 06/2009
2	Breast Neoplasms (Breast Cancer) 01/2016 - 02/2014
2	Heart Diseases (Heart Disease) 01/2016 - 04/2012
2	Exanthema (Rash) 11/2010 - 02/2009
2	Edema (Dropsy) 11/2010 - 05/2008
2	Hepatocellular Carcinoma (Hepatoma) 11/2010 - 02/2007
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 02/2010 - 06/2009
1	Kyphosis 10/2022
1	Heart Failure 01/2022
1	Body Weight (Weight, Body) 01/2022

Drug/Important Bio-Agent (IBA)

10	Chimeric Antigen ReceptorsIBA 07/2021 - 01/2014
8	ibrutinibIBA 12/2017 - 08/2013
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2012
7	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 08/2013
7	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 11/2012
6	Tyrosine Kinase InhibitorsIBA 01/2019 - 02/2009
6	isothiocyanic acidIBA 11/2010 - 01/2004
5	AntibodiesIBA 01/2021 - 11/2012
5	EnzymesIBA 01/2021 - 12/2006
5	Monoclonal AntibodiesIBA 11/2019 - 10/2012
5	blinatumomabIBA 01/2019 - 11/2012
5	Imatinib Mesylate (Gleevec)FDA Link 11/2010 - 05/2004
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 04/2013
4	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 05/2006
4	Messenger RNA (mRNA)IBA 10/2011 - 08/2006
3	B-Cell Maturation AntigenIBA 01/2020 - 01/2019
3	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2018 - 11/2011
3	ErbB Receptors (EGF Receptor)IBA 01/2017 - 04/2016
3	phenethyl isothiocyanate (PEITC)IBA 05/2016 - 08/2004
3	Histones (Histone)IBA 01/2016 - 01/2010
3	Phosphotransferases (Kinase)IBA 01/2016 - 08/2013
3	Prednisone (Sone)FDA LinkGeneric 01/2014 - 08/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014 - 08/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 08/2012
3	DNA (Deoxyribonucleic Acid)IBA 02/2010 - 01/2004
2	Tumor Biomarkers (Tumor Markers)IBA 05/2022 - 01/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2021 - 11/2011
2	AntigensIBA 07/2021 - 01/2019
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 01/2019
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2020 - 11/2019
2	ElastinIBA 01/2020 - 01/2018
2	Biological ProductsIBA 01/2020 - 01/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 08/2013
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019 - 01/2014
2	Inotuzumab OzogamicinIBA 01/2019 - 01/2019
2	Gemtuzumab (Mylotarg)FDA Link 01/2019 - 01/2019
2	gilteritinibIBA 01/2019 - 01/2019
2	Lenalidomide (CC 5013)FDA Link 10/2018 - 11/2012
2	CaspasesIBA 12/2017 - 01/2004
2	osimertinibIBA 01/2017 - 01/2016
2	AndrogensIBA 05/2016 - 01/2004
2	selinexorIBA 01/2015 - 10/2014
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2015 - 03/2006
2	Rituximab (Mabthera)FDA Link 10/2012 - 08/2012
2	Vincristine (Oncovin)FDA LinkGeneric 10/2012 - 08/2012
2	IpilimumabIBA 03/2012 - 02/2012
2	Vorinostat FDA Link 02/2010 - 06/2009
2	ChromatinIBA 02/2010 - 05/2006
2	Histone Deacetylase InhibitorsIBA 02/2010 - 06/2009
2	IsothiocyanatesIBA 12/2006 - 05/2006
2	CarcinogensIBA 12/2006 - 05/2006
2	Temozolomide (Temodar)FDA LinkGeneric 06/2004 - 08/2002

Therapy/Procedure

38	Therapeutics 10/2021 - 03/2006
18	Immunotherapy 07/2021 - 09/2015
10	Drug Therapy (Chemotherapy) 01/2021 - 05/2005
3	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2021 - 12/2018
2	Induction Chemotherapy 10/2021 - 07/2005
2	Endoscopes 02/2014 - 06/2009
1	Traction 10/2022
1	Perioperative Period 10/2022